Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,529 JPY | +0.72% | -4.56% | -12.08% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.08% | 236M | |
+30.28% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.79% | 239B | |
+9.70% | 210B | |
-7.53% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 4554 Stock
- News Fuji Pharma Co., Ltd.
- Alvotech, Fuji Pharma Win Marketing Approval in Japan for Stelara Biosimilar